12.20.23 -- Site Selection And Design Tips For NDDs

Examine several considerations when selecting a technology platform that can create operational efficiencies, reduce site burdens, and ensure accurate data collection throughout a clinical trial.

Explore the benefits of DCTs compared to traditional trials and review relevant examples and guidance on selecting the most suitable type of remote trial for a specific study.

See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

Learn how recruitment and screening of potential patients was made possible for a Phase 3, adult patient, clinical trial by utilizing MRUs to screen large volumes of patients at community events.

Delve into in-depth analyses of key diseases, players, and geographies influencing the pharmaceutical industry through an overview of Phase 1-3 clinical trials initiated in 2022 across all therapeutic areas.

Discover why financial toxicity has historically plagued oncology research, what the industry can do to remove these impediments, and what important advocacy work is being conducted right now.

Experts in trial design and artificial intelligence discuss innovative trial designs that combine the best of biopharma and technology to bring value to the patient.

Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.

Uncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience.

This comprehensive guide empowers medical researchers to ensure the availability of critical lab samples, minimize errors, and enhance data integrity.

Joanne Malia of Regeneron and Janice Cassamajor of Phlexglobal share a blueprint for a partnering model producing measurable benefits, including improved TMF quality, completeness, and timeliness.

Delve into a solution that ensures the efficient delivery of trial materials worldwide, while navigating the challenges of more complex study designs and the ever-evolving regulatory landscape.

Unearth how a trial design solution was able to utilize historical trial data and real-life examples across different indications throughout the clinical development process in five case studies.

Learn how significant experience with natural history studies, precision medicine, and real-world data planning, trial design, and regulatory strategy can guide rare disease product development.

Examine how printing labels with speed, efficiency, reliability, and accuracy can help ensure clinical trial timeline accuracy and improve the potential for successful NDAs.